AlphaQuest’s Korro Bio KRRO Stock Holding History

AlphaQuest’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,703	Closed	-$61.7K	–	1082
2025 Q4	$61.7K	Buy	7,703 +5,235	+212%	+$122K	﹤0.01%	1886
2025 Q3	$118K	Sell	2,468 -24,743	-91%	-$549K	0.01%	1650
2025 Q2	$340K	Buy	27,211 +18,015	+196%	+$259K	0.03%	816
2025 Q1	$160K	Buy	9,196 +7,007	+320%	+$208K	0.02%	1090
2024 Q4	$83.3K	Buy	2,189 +412	+23%	+$21.2K	0.01%	1152
2024 Q3	$59.4K	Buy	1,777 +1,124	+172%	+$47.3K	0.01%	1380
2024 Q2	$22.1K	Buy	+653	New	+$36.1K	﹤0.01%	1288

Other funds holding KRRO

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

AlphaQuest's KRRO Position: Q1 2026 in Review

AlphaQuest sold out of Korro Bio (KRRO) in Q1 2026, closing a stake of 7,703 shares — an estimated $61.7K sold.

AlphaQuest first reported a position in KRRO in Q2 2024 and held it in 7 quarters. The position peaked at $340K in Q2 2025. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

AlphaQuest reported no remaining Korro Bio position as of Q1 2026 after selling out during the quarter.
AlphaQuest sold 7,703 Korro Bio shares in Q1 2026, an estimated $61.7K.
AlphaQuest first reported a position in Korro Bio in Q2 2024 and held it in 7 quarters.
AlphaQuest's Korro Bio position peaked at $340K in Q2 2025.
99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.